An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients
Clinical trial NCT03897205 · COMPLETED
Trial details
- NCT number
- NCT03897205
- Sponsor
- Hansa Biopharma AB
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-30
- Primary completion
- 2022-05-28
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.